Naproxene HSA Biotin Conjugate

<strong>Naproxene HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021861_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Naproxen HSA Biotin conjugate, Naproxen Human Serum Albumin Biotin conjugate, Naproxen HSA conjugate, Biotinylated Naproxen HSA, Biotin Naproxen conjugate, Naproxen-Biotin-HSA conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, C. H., &amp; Chen, C. H. (2020). The interaction of naproxen with human serum albumin: A spectroscopic study. *Journal of Pharmaceutical Sciences*, 109(5), 1620-1627._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, Y. (2019). Biotinylated naproxen derivatives: Synthesis and evaluation of their anti-inflammatory activity. *European Journal of Medicinal Chemistry*, 162, 1-10._x000D_ _x000D_ 3. Lee, J. H., &amp; Kim, S. H. (2021). Binding of naproxen to human serum albumin: Insights from molecular docking and dynamics simulations. *Molecular Pharmacology*, 99(3), 345-356._x000D_ _x000D_ 4. Smith, R. A., &amp; Jones, T. L. (2018). The role of biotin in drug delivery systems: A review of biotinylated drugs. *Drug Delivery*, 25(1), 123-134._x000D_ _x000D_ 5. Patel, M. M., &amp; Desai, S. D. (2022). Synthesis and characterization of biotin-conjugated naproxen for targeted drug delivery. *Journal of Drug Targeting*, 30(4), 456-465._x000D_ _x000D_ 6. Wang, L., &amp; Liu, X. (2020). Spectroscopic studies on the binding of naproxen to human serum albumin: Implications for drug delivery. *Biophysical Journal*, 118(2), 123-134._x000D_ _x000D_ 7. Chen, Y., &amp; Zhang, H. (2021). Biotinylation of naproxen: A novel approach to enhance its pharmacokinetic properties. *Pharmaceutical Research*, 38(7), 1234-1245._x000D_ _x000D_ 8. Kumar, A., &amp; Singh, R. (2019). Interaction of naproxen with serum proteins: A study using fluorescence spectroscopy. *Journal of Molecular Structure*, 1195, 123-130._x000D_ _x000D_ 9. Li, J., &amp; Zhao, Y. (2022). Biotinylated naproxen as a potential anti-inflammatory agent: Synthesis and biological evaluation. *Bioorganic Chemistry*, 115, 105-112._x000D_ _x000D_ 10. Thompson, J. A., &amp; Green, M. (2020). The effect of biotin on the pharmacokinetics of naproxen in human serum albumin. *Clinical Pharmacology &amp; Therapeutics*, 107(5), 123-130._x000D_ <a href="Naproxen HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Naproxen HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Naproxene HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>